Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0155339 (
Brown
)
12,436
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human
TRP-1
has been immunopurified from normal human melanocytes cultured from black neonatal subjects and used to investigate the catalytic function of
TRP-1
for the two substrates, L-tyrosine and L-DOPA. Immunopurified
TRP-1
did not demonstrate DOPA staining on SDS/PAGE nor DOPA oxidase (DO) activity with either routine or modified assays. The purified
TRP-1
also demonstrated no tyrosine hydroxylase (TH) activity using the routine Pomerantz assay. However, there was apparent TH activity exhibited by immunopurified
TRP-1
under conditions with low tyrosine concentration (< or = 0.8 microCi/ml of 3H-tyrosine), prolonged incubation time (i.e., overnight) and in the absence of the cofactor L-DOPA. Using these latter specific conditions, TH activity was also detected in cell lysates from a tyrosinase-negative albino melanocyte line which exhibited no TH activity with the routine Pomerantz assay. In addition, TH activity under low substrate assay conditions was not exhibited in a melanocyte line derived from a
TRP-1
deficient,
Brown
albino individual. However, the absence of TH in this
Brown
albino cell line could be compensated for by the addition of L-DOPA to the assay. These results suggested that
TRP-1
has some tyrosine hydroxylase but no DOPA oxidase activity. We propose that one function of
TRP-1
is to modulate tyrosinase activity by making DOPA available as a cofactor to perpetuate the initial steps in melanogenesis.
...
PMID:Human TRP-1 has tyrosine hydroxylase but no dopa oxidase activity. 797 45